3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Fallopian Tube Neoplasms
5
Ovarian Neoplasms
4
Carcinoma, Ovarian Epithelial
3
Neoplasms
2
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Metastatic Castration Resistant Prostate Cancer
1
Genital Neoplasms, Male
1
Adenocarcinoma, Clear Cell
1
Interventions
Abiraterone Acetate
2
rucaparib
1
enzalutamide
1
Prednisone
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Metastatic Castration Resistant Prostate Cancer
×
rucaparib
×
Clear all
NCT02975934
2025-07-25
TRITON3
pharmaand GmbH
Phase 3
Completed
405 enrolled
34 charts
1 FDA